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(laparoscopic) (lapar-Abstract Objectives: To review the current literature comparing the outcomes of
renal surgery via open, laparoscopic and robotic approaches.
Materials and methods: A comprehensive literature search was performed on
PubMed, MEDLINE and Ovid, to look for studies comparing outcomes of renal
surgery via open, laparoscopic, and robotic approaches.
Results: Limited good-quality evidence suggests that all three approaches result
in largely comparable functional and oncological outcomes. Both laparoscopic
and robotic approaches result in less blood loss, analgesia requirement, with a
shorter hospital stay and recovery time, with similar complication rates when com-
pared with the open approach. Robotic renal surgeries have not shown any signifi-
cant clinical benefit over a laparoscopic approach, whilst the associated cost is
significantly higher.7 7DN,
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(robot-assisted) pyelo-
plasty;
RCT, randomised
controlled trial;
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(laparoscopic) (open)
(robot-assisted) radical
nephrectomy;
WIT, warm ischaemia
timelease cite this article in press as: Luk ACOConclusion: With the high cost and lack of overt clinical benefit of the robotic
approach, laparoscopic renal surgery will likely continue to remain relevant in treat-
ing various urological pathologies.
 2018 Production and hosting by Elsevier B.V. on behalf of Arab Association of
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Laparoscopy in humans was first performed >100 years
ago by the Swedish surgeon Hans-Christian Jacobaeus;
to which he originally named the technique laparotho-
rakoskopie [1]. Initially only performed for diagnostic
purposes, several landmark innovations over the last
century, such as the Trendelenburg position and the
Hopkins rods-lens system, have paved the way for more
complex operations to be performed via a laparoscopic
approach [2].
The first laparoscopic renal surgery was performed in
1990 by Clayman et al. [3] from Washington, USA; in
the New England Journal of Medicine they described
the first case of laparoscopic nephrectomy, which
involved a 7-h operation on an 85-year-old woman’s
3-cm solitary right renal mass. As laparoscopic nephrec-
tomy became more widespread, more advanced and
complicated procedures were developed. In 1995, the
first series of partial nephrectomies (PNs) was published
by Winfield et al. [4], and in Johns Hopkins University
the first laparoscopic donor nephrectomy (LDN) was
performed by Su et al. [5]. Whilst the propagation of
laparoscopic renal surgery was initially hampered by a
significant learning curve and longer operation time, as
more experience was accumulated new evidence showed
laparoscopic outcomes to be comparable to an openet al. Laparoscopic renal surgery is herapproach, with the added advantage of significantly less
blood loss, analgesia requirement, and length of hospital
stay (LOS) [2,6].
Laparoscopic nephrectomy is now routinely per-
formed for both benign and malignant pathologies, as
well as DNs in renal transplantation. Laparoscopic
PN (LPN) has also seen widespread use, as nephron-
sparing surgery has been set as the ‘gold standard’ for
managing small renal tumours. In centres with laparo-
scopic expertise, laparoscopic pyeloplasty has been
increasingly performed for PUJ obstruction (PUJO).
With the advancement of robotic surgery, urology
has been at the forefront in this regard, particularly
for pelvic surgeries such as robotic prostatectomies
[7]. Much interest has been shown in applying the
robotic system to renal surgery, with its advantages of
improved ergonomics, dexterity, and reduced physical
strain on the operating surgeon [8]. However, to date,
the cost of robotic systems remains a major stumbling
block in widely implementing them; whilst there are
limited comparative studies demonstrating out-right
improvements in outcome when compared with estab-
lished techniques.
The present review aims to gather evidence on rele-
vant outcomes of renal surgeries (in particular, nephrec-
tomy, PN, and pyeloplasty) performed via open,
laparoscopic and robotic approaches, to ascertaine to stay, Arab J Urol (2018), https://doi.org/10.1016/j.aju.2018.01.003
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over the other in the three respective operations.
Materials and methods
A comprehensive literature review was performed on
PubMed, MEDLINE, and Ovid between 1995 and
2017. Medical Subject Headings (MeSH) terms used
for the search were ‘open’, ‘laparoscopic’, ‘robotic’,
‘nephrectomy’, ‘partial nephrectomy’, and ‘pyeloplasty’.
Records were evaluated in accordance with the Pre-
ferred Reporting Items for Systemic Reviews and
Meta-Analyses (PRISMA) criteria. Inclusion criteria
were studies that focused on: comparing the immediate,
short-term and long-term outcomes of either nephrec-
tomy, PN, and pyeloplasty performed either via open,
laparoscopic or robotic approach.
Exclusion criteria were: (i) studies not in English, (ii)
studies that did not look at postoperative outcomes, (iii)
studies in which laparoscopic approach was not per-
formed as a comparator, (iv) letters and commentaries,
and (v) studies with poor design. See Fig. 1 for the stud-
ies selection numbers.
Results and discussion
Radical nephrectomy (RN)
RN is considered a curative treatment for localised
RCC, whilst retaining some roles in locally advanced
and advanced/metastatic diseases [6]. It is also the first
kind of renal surgery performed laparoscopically [3].Fig. 1 Flow diagram of studies’ selection.
Please cite this article in press as: Luk ACO et al. Laparoscopic renal surgery is herData from several randomised controlled trials
(RCTs) comparing open RN (ORN) and laparoscopic
RN (LRN) demonstrated significantly less analgesia
requirement, shorter LOS, shorter convalescence time,
and less blood loss intraoperatively in LRN, whilst the
transfusion rate, operative time and surgical complica-
tionswere similar [9–11]. One prospective series suggested
postoperative quality-of-life scores were similar [12].
Two RCTs reviewed the retroperitoneal and
transperitoneal approach for LRN; overall there are
no significant differences in patient morbidity, surgical
outcomes, and technical difficulties [13,14].
The only data available for long-term oncological
outcomes between LRN and ORN are from compara-
tive series, many of which are of low methodology qual-
ity. No differences in overall and cancer-specific survival
were found with a follow-up of up to 5 years [12,15–18].
A retrospective series, looking at pT3 tumours in partic-
ular, also did not find any differences in survival with a
mean follow-up of 28 and 58 months for LRN and
ORN, respectively [19].
There are limited comparison data between robot-
assisted RN (RARN) and LRN; in the single prospective
comparative study identified, other than a longer opera-
tive time in RARN, no significant differences were found
in estimated blood loss, intra/postoperative complica-
tions, LOS, analgesia requirements, and convalescence
[20]. The study had a small sample size, and a mere
follow-up period of<1 year, with no cases of recurrence.
Several retrospective series of heterogenic surgical tech-
niques also did not show significantly different short-
term outcomes between RARN and LPN [21–24]. A ret-
rospective series using the Nationwide Inpatient Sample
database in the USA suggested that when compared with
LRN, RARN increases medical expenses without con-
ferring an improvement to patient morbidity, with an
increase of an estimated $4565 (American dollars) and
$11 267 to hospital costs and charges, respectively [25].
When compared with ORN, LRN gives the advan-
tage of shorter recovery (LOS, convalescence), less anal-
gesia requirement and intraoperative blood loss, with
similar oncological outcomes even in high-stage
tumours. At present there is lack of studies comparing
RARN and LRN, and what is available does not sug-
gest any significant advantage of RARN over LRN.
Donor nephrectomy (DN)
The preferred approach for living-DN in established
kidney transplant centres is laparoscopic [26]. In centres
where the facility for laparoscopy is not available, the
open approach, preferably by a mini-incision, is still a
valid option [27].
The evidence supporting LDN arose from several sys-
tematic reviews and meta-analyses [28,29]. A Cochrane
review, which analysed six RCTs (596 participants)e to stay, Arab J Urol (2018), https://doi.org/10.1016/j.aju.2018.01.003
4 Luk et al.comparing LDN vs an open approach for DN, con-
cluded that LDN is associated with less pain, shorter
LOS, and earlier return to normal physical activities,
with no significant differences in postoperative compli-
cations; although the warm ischaemia time (WIT) was
longer in the LDN group, this was not associated with
any short-term consequences [30].
Another Cochrane review, which included three
RCTs (179 participants) comparing laparoendoscopic
single-site DN (LESS-DN) with LDN, suggested com-
parable operative time, blood loss, complication rates,
WIT, LOS, and time to return to normal activities; pain
scores at discharge was significantly less in the LESS-
DN group (two studies, 79 patients: mean difference
1.19, 95% CI 2.17 to 0.21) [31].
In a small series comparing transvaginal natural ori-
fice transluminal endoscopic surgery (NOTES)-assisted
LDN with LDN (20 patients in each arm) in living
donors, NOTES-assisted LDN appeared to be a safe
and feasible surgical technique; the WIT was longer in
the NOTES-assisted approach; however, this did not
affect graft function [32].
A retrospective controlled trial comparing robot-
assisted vs hand-assisted LDN, with 25 patients in the
robot-assisted arm and 36 patients in the hand-assisted
arm, showed comparable outcomes for recipient crea-
tinine at discharge and postoperative complications
[33]. The operative duration was longer for the robot-
assisted arm (309 vs 135 min, statistically nonsignifi-
cant), whilst most of the patients in the robot-assisted
arm were discharged within 4 days (15/25, 60% vs
10/36, 27%; P= 0.02).
Partial nephrectomy (PN)
PN is now the ‘gold standard’ for treating small renal
tumours [6,34]; much interest has therefore arisen in per-
forming this procedure in a minimally invasive fashion.
Multiple series (mostly retrospective, none con-
trolled) have compared open PN (OPN) with LPN;
LPN was generally found to have a longer WIT [35–
38] and operative time [36,39], but a lower mean esti-
mated blood loss when compared to OPN [35–37].
One retrospective study in Japan found that in patients
who underwent LPN, high body mass index (BMI; 25
kg/m2) did not confer longer operative time and higher
estimated blood loss when compared to a normal BMI
group, whilst patients who had OPN did, suggesting a
possible benefit of LPN in patients with high BMIs
[37]. Postoperative complications were generally
reported to be similar in both groups [35,36,40].
A USA retrospective analysis using the Premier
Healthcare Database looked at incidents of unsuccessful
PNs (requiring conversion to RN) between 2003 and
2015 and found the rate to be highest in LPN
(34.7%), and lowest in robot-assisted PNs (RAPNs)Please cite this article in press as: Luk ACO et al. Laparoscopic renal surgery is her(13.6%); however, there were significant differences
between surgeons with different caseload volumes, and
it was noted that the overall conversion rate to RNs
has dropped dramatically from 33.5% in 2003 to
14.5% in 2015 [41].
The functional and oncological outcomes are compa-
rable between LPN and OPN. No differences were
found in overall survival and progression-free survival
rate between LPN and OPN [36,37,40,41]. In a
matched-pair comparison, estimated GFR (eGFR)
decline 24 h after surgery was significantly higher in
LPN (P< 0.001), but no decline was identified in a
mean follow-up period of 3.6 years [40]. In another ret-
rospective comparative study, operative approach (OPN
vs LPN) was not found to be an independent risk factor
for development of chronic kidney disease (eGFR < 60
mL/min/1.73 m2) after 5 years of follow-up [38].
The advancement of surgical robotic technology has
been applied to LPNs in recent years; in particular, it
has been advocated that the robot can facilitate renor-
rhaphy and reduce the learning curve of laparoscopic
suturing [42]. However, at present, there are only a lim-
ited number of comparative studies examining the effi-
cacy of RAPN over LPN, many of which are
experiences of a single surgeon with no randomisation.
They suggest that RAPN may have an advantage over
LPN with shorter WIT, operating time and estimated
blood loss [42–46]. Generally no differences were found
in LOS, postoperative complications, and change in
eGFR [42–47]. No difference in the positive surgical mar-
gin rate was found between the two approaches [43,45].
To date no studies have examined the long-term onco-
logical outcomes between LPN and RAPN [46].
One retrospective comparative study in a single cen-
tre examining RAPN and LPN in complex small renal
masses (R.E.N.A.L.[Radius; Exophytic/Endophytic;
Nearness; Anterior/Posterior; Location] nephrometry
score 7) did not find any significant differences in
WIT, estimated blood loss, transfusion rate, postopera-
tive complications, and decrease in eGFR; however,
LPN was associated with a significantly higher conver-
sion rate to RN (P< 0.001) [47].
LPN remains a challenging surgical procedure at
times, but it has shown comparable functional and
oncological outcomes to OPN. There is less estimated
blood loss, and in patients with high BMI it may be a
better approach, taking into account that there is a
higher rate of conversion to RN. RAPN has shown
some intraoperative benefits compared to LPN, but
more studies are required to examine its long-term onco-
logical results to fully justify the cost.
Pyeloplasty
Pyeloplasty is a well-recognised surgical treatment for
symptomatic PUJO in both children and adults [48].e to stay, Arab J Urol (2018), https://doi.org/10.1016/j.aju.2018.01.003
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resulted in the first case of laparoscopic pyeloplasty
(LPY) being performed in 1993 [49]. The number of
LPY being performed has risen dramatically since, with
the number of robot-assisted PY (RAPY) on the rise
recently [50].
Major LPY case series found low rates of periopera-
tive morbidities and high success rates, in both retroperi-
toneal and transperitoneal approaches [51–54]. Studies
using renal scintigraphy to confirm postoperative LPY
success have shown this to be between 92% and
95.6% [55,56]. A symptom-free success-rate was
reported to be 95% [57].
When comparing with open PY (OPY), multiple
comparative series suggested that LPY may have a
longer operating time, but with a significantly shorter
LOS and analgesia requirement, and no difference in
complications and postoperative success rates [58–60].
A randomised controlled study comparing the two
modalities had similar findings to the comparative ser-
ies; the mean total operative time was 244.2 vs 122
min, LOS was 3.14 vs 8.29 days, and duration of analge-
sia was 1 vs 3.14 days for LPY and OPY respectively,
with similar success rates [61].
One comparative study looked at re-do pyeloplasty
via a laparoscopic or open approach (after a failed ini-
tial OPY) in the paediatric population; LPY had a sig-
nificantly shorter LOS and lower pain score, but with
a longer operative time; no significant differences in esti-
mated blood loss, complications and success rates were
observed [62].
RAPY has been proposed to have an advantage over
LPY by having a shorter learning curve and suturing
time; however, at present there are no well-designed
RCTs comparing effectiveness between LPY and RAPY
[63]. Several comparative series have suggested that
RAPY benefits from having a shorter operative time
when compared with LPY, but no other differences were
found [59,63–65]. A population-based study using the
USA Perspective Database found that the median cost
of RAPY was significantly higher than OPY, whilst
there was no statistical difference between the median
cost of OPY and LPY [50].
Overall, all three approaches (OPY, LPY, and
RAPY) have comparable outcomes, with differences lar-
gely confined to operative time, LOS, and analgesia
requirement. RAPY is still largely prohibited by the cost
of the robotic instruments, with LPY likely to continue
playing an important role.
Conclusion
Evidence with good methodological quality in compar-
ing the outcome (in particular, long-term) of renal sur-
gery is unfortunately scarce, probably due to the
practical issues of conducting such trials. The data avail-Please cite this article in press as: Luk ACO et al. Laparoscopic renal surgery is herable to date suggest very similar functional and oncolog-
ical outcomes of renal surgery regardless of using a
laparoscopic, open or robotic approach. A minimally
invasive approach (laparoscopic and robotic) confers
less blood loss, analgesia requirement, with a shorter
LOS and recovery time. An open approach on the other
hand often results in shorter operative time, and whilst
this may be important due to the impact on WIT in
PN and DN, this does not transfer to a better functional
outcome when compared with a laparoscopic/robotic
approach.
Robotic surgery has often been hailed as the next
stage of evolution in minimally invasive surgery. But
to date there are no overt benefits demonstrated when
comparing between the robotic and laparoscopic
approach in renal surgery. Given the significantly higher
cost associated as well, it is unlikely that robotic renal
surgery will soon become the norm. Another determin-
ing factor will be individual surgeon’s preference, expe-
rience, and local resource availability. Given its
widespread use already, laparoscopic renal surgery will
still retain a significant role to play in the near future.
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